A citation-based method for searching scientific literature

Morgan L Maeder, Michael Stefanidakis, Christopher J Wilson, Reshica Baral, Luis Alberto Barrera, George S Bounoutas, David Bumcrot, Hoson Chao, Dawn M Ciulla, Jennifer A DaSilva, Abhishek Dass, Vidya Dhanapal, Tim J Fennell, Ari E Friedland, Georgia Giannoukos, Sebastian W Gloskowski, Alexandra Glucksmann, Gregory M Gotta, Hariharan Jayaram, Scott J Haskett, Bei Hopkins, Joy E Horng, Shivangi Joshi, Eugenio Marco, Rina Mepani, Deepak Reyon, Terence Ta, Diana G Tabbaa, Steven J Samuelsson, Shen Shen, Maxwell N Skor, Pam Stetkiewicz, Tongyao Wang, Clifford Yudkoff, Vic E Myer, Charles F Albright, Haiyan Jiang. Nat Med 2019
Times Cited: 287



Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis, Adam D Cohen, Kristy L Weber, Eric Lancaster, Patricia A Mangan, Irina Kulikovskaya, Minnal Gupta, Fang Chen, Lifeng Tian, Vanessa E Gonzalez, Jun Xu, In-Young Jung, J Joseph Melenhorst, Gabriela Plesa, Joanne Shea, Tina Matlawski, Amanda Cervini, Avery L Gaymon, Stephanie Desjardins, Anne Lamontagne, January Salas-Mckee, Andrew Fesnak, Donald L Siegel, Bruce L Levine, Julie K Jadlowsky, Regina M Young, Anne Chew, Wei-Ting Hwang, Elizabeth O Hexner, Beatriz M Carreno, Christopher L Nobles, Frederic D Bushman, Kevin R Parker, Yanyan Qi, Ansuman T Satpathy, Howard Y Chang, Yangbing Zhao, Simon F Lacey, Carl H June. Science 2020
Times Cited: 547




List of shared articles



Times cited

New approaches to moderate CRISPR-Cas9 activity: Addressing issues of cellular uptake and endosomal escape.
Maja van Hees, Sofie Slott, Anders Højgaard Hansen, Heon Seok Kim, Hanlee P Ji, Kira Astakhova. Mol Ther 2022
6

Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges.
Eman A Taha, Joseph Lee, Akitsu Hotta. J Control Release 2022
11

CRISPR-based genome editing through the lens of DNA repair.
Tarun S Nambiar, Lou Baudrier, Pierre Billon, Alberto Ciccia. Mol Cell 2022
14

Basic Principles and Clinical Applications of CRISPR-Based Genome Editing.
Jung Min Lim, Hyongbum Henry Kim. Yonsei Med J 2022
2

Reverting TP53 Mutation in Breast Cancer Cells: Prime Editing Workflow and Technical Considerations.
Asmaa Y Abuhamad, Nurul Nadia Mohamad Zamberi, Ling Sheen, Safaa M Naes, Siti Nur Hasanah Mohd Yusuf, Asilah Ahmad Tajudin, M Aiman Mohtar, Amir Syahir Amir Hamzah, Saiful Effendi Syafruddin. Cells 2022
1

The origin of unwanted editing byproducts in gene editing.
Jianhang Yin, Jiazhi Hu. Acta Biochim Biophys Sin (Shanghai) 2022
2

Therapeutic in vivo delivery of gene editing agents.
Aditya Raguram, Samagya Banskota, David R Liu. Cell 2022
10

Message in hand: the application of CRISPRi, RNAi, and LncRNA in adenocarcinoma.
Ting Wang, Yunhong Yao, Xinrong Hu, Yi Zhao. Med Oncol 2022
0


A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing.
Xin-Zhu Chen, Rong Guo, Cong Zhao, Jing Xu, Hang Song, Hua Yu, Christian Pilarsky, Firzan Nainu, Jing-Quan Li, Xin-Ke Zhou,[...]. Front Pharmacol 2022
0

Genome editing-mediated knock-in of therapeutic genes ameliorates the disease phenotype in a model of hemophilia.
Jeong Hyeon Lee, Hye-Kyung Oh, Beom Seok Choi, Ho Hyeon Lee, Kyu Jun Lee, Un Gi Kim, Jina Lee, Hyerim Lee, Geon Seong Lee, Se Jun Ahn,[...]. Mol Ther Nucleic Acids 2022
1

Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors.
Marta García, Jose Bonafont, Jesús Martínez-Palacios, Rudan Xu, Giandomenico Turchiano, Stina Svensson, Adrian J Thrasher, Fernando Larcher, Marcela Del Rio, Rubén Hernández-Alcoceba,[...]. Mol Ther Methods Clin Dev 2022
0

CRISPR/Cas systems usher in a new era of disease treatment and diagnosis.
Ruiting Li, Qin Wang, Kaiqin She, Fang Lu, Yang Yang. Mol Biomed 2022
0

CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside.
Olivier Humbert, Clare Samuelson, Hans-Peter Kiem. Br J Haematol 2021
1

Bioanalytical challenges and strategies of CRISPR genome editors.
Mikko Hölttä, Roberto Nitsch, Neil Henderson. Bioanalysis 2021
0

Cas9-directed immune tolerance in humans-a model to evaluate regulatory T cells in gene therapy?
Dimitrios Laurin Wagner, Lena Peter, Michael Schmueck-Henneresse. Gene Ther 2021
13